| Drug candidate | Indication | Research | Pre- clinical |
Phase I | Phase II | Phase III | |
| 1) INJECTABLES | |||||||
| SP1049C | Upper GI | ** | SPA | ||||
| SP1049C | NSCLC | ** | |||||
| SP1049C | Colorectal | ** | |||||
| SP1063C | Colorectal | * | |||||
| SP1031C | Hematological | * | |||||
| 2) ORAL CYTOTOXICS | |||||||
| SP1060C-O | Ovarian | * | |||||
| SP1060C-O | SCLC | * | |||||
| SP1062C-O | Colorectal | ** | |||||
| 3) TARGETED THERAPY | |||||||
| SP-MET-X1 | Breast, Colorectal, Melanoma |
* | |||||
| * | In progress | ||||||
| ** | Completed |
